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The conventional auscultatory methods for measuring blood pressure have been used 
to screen, diagnose, and manage hypertension since long. However, these have been 
found to be prone to errors especially the white coat phenomena which cause falsely 
high blood pressure readings. The Mercury sphygmomanometer and the Aneroid vari-
ety are no longer recommended by WHO for varying reasons. The Oscillometric devices 
are now recommended with preference for the Automated Office Blood Pressure meas-
urement device which was found to have readings nearest to the Awake Ambulatory 
Blood Pressure readings. The downside for this device is the cost barrier. The alterna-
tive is to use the simple oscillometric device, which is much cheaper, with the rest and 
isolation criteria of the SPRINT study. This too may be difficult due to space constraints 
and the post-clinic blood measurement is a new concept worth further exploration.
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1  |  INTRODUC TION
In 2015, the global prevalence of hypertension was estimated to be 
more than 1.1 billion.1 The highest prevalence of raised blood pres-
sure (BP) among people aged ≥18 years was in low-income countries 
(28.4%) and middle-income countries (25.5%). In 2017, the Global 
Burden of Disease study found that raised systolic blood pressure 
(SBP) was the leading modifiable risk factor for death globally, with 
10.4 million deaths annually attributed to this cause.2
The diagnosis of hypertension has classically been made by 
office/clinic BP measurements. This has evolved over time from 
Mercury sphygmomanometers to Aneroid, Hybrid (quasi-mercury) 
and then Oscillometric devices.3,4 However, there have been mul-
tiple problems in obtaining correct BP readings in the office. These 
include observer errors caused by lack of concentration, poor hear-
ing, confusion of auditory, and visual cues, etc. The most important 
factor is failure to interpret the Korotkoff sounds accurately, espe-
cially for diastolic blood pressure (DBP). Terminal digit preference 
and observer bias are also causes of inaccurate measurements.5
Device problems are also common. In a study of 210 mercury 
and aneroid sphygmomanometer, nearly half had some fault.6 
Methodology errors, which are mostly due to inadequate attention 
to the recommended guidelines, are a major cause of inaccuracy 
of BP measurement. BP is rarely measured in accordance with the 
strict guidelines in a screening or clinical setting, and the accuracy of 
measurement is often disregarded or ignored.7 In a study of 150 pa-
tients, BP measured by usual care was compared with that measured 
strictly following the American Heart Association guidelines. There 
was a mean lowering of about 12/6 mmHg when the guidelines were 
followed.8
Another major problem with office blood pressure (OBP) mea-
surements is the alerting response which causes the white coat 
phenomena seen as white coat hypertension in non-hypertensives 
and white coat effect in known hypertensives.3,4,7,9 The pressor and 
tachycardiac responses to the alerting reaction that accompanies 
sphygmomanometric blood pressure measurement is characterized 
by a behavior of the adrenergic nervous system that causes mus-
cle sympathoinhibition and skin sympathoexcitation.10 In a study 
by Dolan et al, the overall prevalence of white coat hypertension 
was 15.4% and a higher prevalence was seen among older adults, 
females, and non-smokers.11 This is seen more often when doc-
tors measure the BP and less so with nurses.12,13 It is not due to 
device error as the oscillometric home blood pressure measurement 
(HBPM) gives lower BP readings at home but the same device when 
used in a clinical setting in the Spanish ABPM registry gave markedly 
higher BP readings.14
The inability to diagnose masked hypertension is another draw-
back of OBP as by definition, masked hypertension in untreated hy-
pertensive patients or masked uncontrolled hypertension (MUCH) 
in treated hypertensive patients is controlled BP in clinic as mea-
sured by OBP but uncontrolled BP out-of-clinic as measured by 24-h 
ambulatory BP monitoring (ABPM) or by HBPM.15 The prevalence 
in the population is reported as 10%–26% (mean 13%).4 This is 
reported to be more common in smokers, hypertensives on treat-
ment, males, elderly, alcohol consumers, African Americans, diabet-
ics, and chronic kidney disease. In the study by Siddiqui et al, it was 
found that patients with MUCH had evidence of heightened out-of-
clinic sympathetic activity compared with true controlled hyperten-
sive patients.15
Problems with OBP measurements have led to the development 
of various devices and methodologies that have proven to give more 
accurate BP measurements. This includes the HBPM device which 
is used by the patient at home over a period of days or weeks and 
the ABPM device which is usually applied for 24 h and is prepro-
grammed to take measurements at set intervals. The ABPM is now 
regarded as the best technology for BP measurement3,4,16,17 fol-
lowed by HBPM16,18 as both these methods can diagnose masked 
hypertension and avoid the pitfall of white coat hypertension in ad-
dition to other benefits.
This review is limited to the device types and methodologies 
used for BP measurement in the office/clinic only and will not discuss 
HBPM or ABPM. The methodologies employed during measurement 
including the device types, individual measuring or unattended mea-
surements, prior rest period, and timing of measurements will be dis-
cussed. The standardized BP measurement techniques as mentioned 
in the various hypertension guidelines must be followed regardless 
of the methodology employed.3,4,7,16,19 It is also clarified that the 
words office and clinic are used interchangeably in this review.
2  |  DE VICE T YPES
2.1  |  Auscultatory devices
The first group are the auscultatory devices where a trained ob-
server uses a stethoscope to listen to the Korotkoff sounds and 
makes a determination as to the SBP and DBP. Thus, these are all 
prone to the observer errors mentioned above and also to the white 
coat phenomenon as unattended readings are not possible.
2.1.1  |  Mercury sphygmomanometer
This has been the classical way of measurement and has been 
regarded as the gold standard. The validity of newer devices is 
checked against this device. It is inexpensive, requires limited 
maintenance, and requires no energy source. It is still being used 
by a large number of doctors worldwide. In a study of 774 fam-
ily physicians in Canada published in 2017, 54.2% were still using 
the auscultatory methods (which include both mercury and aner-
oid sphygmomanometers) for screening, 21.4% for diagnosis, and 
63.6% for follow-up of hypertension.20 A study of 445 primary 
care doctors in Hong Kong published this year revealed that the 
auscultatory methods were being used by 63.1% for screening, 
56.4% for diagnosis, and 72.4% for follow-up.21 In an unpublished 
study done in Pakistan by Bilal M. and Siddique S., in 500 doctors 
    |  3SIDDIQUE Et al.
(over 2/3rds of these working as junior hospital doctors in the field 
of cardiology), 61% were using mercury sphygmomanometer and 
24% the aneroid variety (personal communication). The problems 
with this instrument are the use of a toxic material, that is, mercury, 
which is being phased out following the Minamata Convention.22 
It is no longer recommended by the World Health Organization 
(WHO) due to the toxic material and should be phased out (WHO 
Technical Specifications for Automated non-invasive BP measur-
ing devices with cuff, p. 6).23
2.1.2  |  Aneroid sphygmomanometer
This device has the advantage of being easy to carry around and 
use, is inexpensive, and needs no energy source. However, it is 
prone to inaccuracy in case of mishandling, for example, physical 
shocks, and needs to be calibrated at fixed intervals (at least every 
6 months).23 Unlike the mercury device in which the mercury level 
can be checked visually, there is no way for the individual performing 
the test to be sure of the accuracy of this device. This device is also 
no longer recommended by WHO because of the requirement for 
frequent recalibration and observer training and retraining (WHO 
Technical Specifications for Automated non-invasive BP measuring 
devices with cuff, p. 6).23
2.1.3  |  Hybrid (quasi-mercury)
An electronically generated pressure column (quasi-mercury) sphyg-
momanometer is a sphygmomanometer using an electronic analog 
column instead of a mercury column.3,4,7 With a hybrid sphygmoma-
nometer, a liquid crystal display column or light-emitting diode screen 
moves smoothly like a mercury column or aneroid-like display. It is an 
auscultatory method and is, therefore, prone to the observer errors 
common to this method including the white coat phenomenon.
2.1.4  |  Automated auscultatory
This is an electronic BP measuring device which uses high sensitiv-
ity microphones to detect the Korotokoff sounds. Thus, the human 
ear is not required and measurements can be fully automated which 
eliminates the white coat effect seen with other auscultatory de-
vices. However, the area of automated BP measurement has been 
virtually taken over by the automated oscillometric technique (dis-
cussed below) and this device is not specifically mentioned in any of 
the major hypertension guidelines.3,4,7,16,19 However, some of these 
do mention validated devices. The dable Educational Trust web site 
makes up-to-date evidence-based information available regarding 
BP devices and lists the BP devices validated under international 
protocols.24 Under its latest listing of recommended Automated 
Devices for Clinical Use, there are over a 100 different devices, the 
vast majority being oscillometric. Only 4 recommended devices have 
auscultatory component. It is therefore a validated methodology 
and as many countries/regions have separate accreditation lists for 
BP devices, it is possible that in certain countries, it may be more 
prevalent.
2.2  |  Oscillometric devices
These are of two types:
The simple type designed for home blood pressure monitoring 
which is also being used in many office practices. The one with the 
upper arm cuff is recommended and not the wrist or finger varieties 
as the latter have not been clinically validated.23 This device has to 
be activated by an individual, either a professional, that is, doctor 
or nurse etc or by the patient. There are reports of having white 
coat phenomena by this process.3,4,16 In 27 211 patients with hyper-
tension in the Spanish ABPM Registry, the mean oscillometric OBP 
was 160/89 mmHg, compared with a mean awake ambulatory blood 
pressure (ABP) of 135/78 mmHg.14 Thus, simply replacing manual 
BP with an oscillometric device did not eliminate the white coat ef-
fect if other parameters like rest, isolation, and unattended BP mea-
surement were not followed.
The professional type, again with the upper arm cuff. This has 
an inbuilt delay before starting the measurement and can be pro-
grammed to do repeated measurements (at least three) with a time 
delay between measurements. This is called the automated office 
blood pressure measurement (AOBP).25 This is the method that 
was employed in the SPRINT study comprising 9316 patients in 
which the SBP by AOBP was found to be similar to SBP of 24 h 
ABP and about 7 mm less than daytime ambulatory SBP.26 In a 
meta-analysis to examine the association between AOBP and 
OBP readings (manual or oscillometric) measured in routine clin-
ical practice and in research studies, and awake ABP, it was found 
that in samples with systolic AOBP of 130 mmHg or more, routine 
office and research SBP readings were substantially higher than 
AOBP readings, with a pooled mean difference of 14.5 mmHg 
(95% CI, 11.8–17.2 mmHg; n = 9; I2 = 94.3%; p < .001) for rou-
tine office SBP readings and 7.0 mmHg (95% CI, 4.9–9.1 mmHg; 
n = 9; I2 = 85.7%; p <  .001) for research SBP readings. There was 
no significant difference in SBP readings between awake ABP and 
AOBP, with a pooled mean difference of 0.3 mmHg (95% CI, −1.1 
to 1.7 mmHg; n = 19; I2 = 90%; p < .001).25 The authors concluded 
that AOBP should now be the preferred method for recording BP 
in routine clinical practice.
There are question marks over the prognostic significance of 
the AOBP measurements.3 However, in a study by Campbell et al in 
176 patients, the AOBP readings correlated better with carotid in-
tima-media thickness than the auscultatory BP.27 Another study 
by Andreadis et al concluded that high-quality AOBP readings and 
ABP measurements correlate equally well with left ventricular mass 
indices.28
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2.3  |  New innovations
There are many new innovations in the market which are cuff-less 
and calculate the BP from various other parameters including Pulse 
transit time, Ultrasound or Magnetic method, Tissue characteris-
tic methods, Machine-learning methods, Heart-rate variation and 
heart-rate power spectrum ratio, Photoplethysmography, Heart 
rate, and smartphone technology. None of these technologies have 
been validated, they are not regulated, and there is no unified, stand-
ard system to evaluate their accuracy, performance, or use. Thus, 
these emerging technologies cannot yet be recommended for clini-
cal use (WHO Technical Specifications for Automated non-invasive 
BP measuring devices with cuff, pp.30–31).23
3  |  METHODOLOGIES
3.1  |  Individual performing the test
3.1.1  |  Doctors
BP readings taken by doctors have been shown to be the most un-
reliable as the worst form of white coat phenomena manifest when 
doctors perform the measurement.12
3.1.2  |  Nurses
It has been uniformly seen in multiple trials that nurses’ BP read-
ings are less than the ones taken by doctors.12 However, the white 
coat phenomenon is not totally nullified and is still seen in these 
readings.13
3.1.3  |  Automated readings
These could be attended or unattended.
Fully automated unattended readings have been shown to be 
the lowest and most compatible with daytime ABPM readings.29 
However, in a study by Julia Holler et al,30 in 42 consecutive pa-
tients with hypertension, attended AOBP was 131.7/83.4 mmHg 
compared with unattended AOBP of 131.6/82.4 mmHg. This was 
contrary to the results of a trial by Berkhof et al.31 Their study 
consisted of 120 patients who performed three self-initiated and 
three fully automated BP measurements. In this cohort (mean age 
58.0 ± 14.1 years, mean OBP 153.6 ± 23.8/86.3 ± 14.0 mmHg, 
44.1% female), self-initiated BP measurement resulted in a 
2.1 ± 6.8/0.9 ± 4.0 mmHg higher systolic and diastolic blood 
pressure (DBP) compared with fully automated self-measurement 
(p = .001/.018). Thus, there was a small but significant reduction 
of both SBP and DBP when the fully automated device was used. 
In another study by Bauer et al,32 unattended to attended AOBP 
were compared in 51 patients. Unattended BP was calculated as 
the mean of 3 automated measurements performed in a separate 
room after 5 min of rest.
Unattended and attended AOBP were 134.2/80.6 and 
135.7/80.6 mmHg. Their conclusion was that unattended and at-
tended office BP measurements achieve comparable results, if mea-
surements take place at a familiar general practitioner’s office. In 
an editorial by Stergio et al, six studies are mentioned which con-
sistently showed that when several OBP measurements are taken 
using automated devices without talking to the patient, the presence 
of the observer has little or no effect on measured OBP (95% CIs in 
all studies excluded any clinically important difference).33 Moreover, 
in a study by Salvetti et al, it was shown that both left ventricular 
mass index and carotid intima-media thickness were similarly cor-
related with attended and unattended systolic BP.34
Another advantage of AOBP shown in trials is that it is fairly con-
stant no matter where it is performed. In a study by Chambers et al,35 
AOBP measurements were obtained in family physicians’ offices and 
were compared with those obtained in community pharmacies in 
275 patients aged 65 years or older. The mean difference between 
the measurements at the two locations was <1.1/0.5 mmHg. Their 
conclusion was that measurements of blood pressure using an au-
tomated device in a pharmacy can provide accurate and valid blood 
pressure information that can be used in the diagnosis and manage-
ment of hypertension among older adults in the community. In an-
other study by Armstrong et al,36 AOBP readings using the BpTRU 
device recorded with the patient resting quietly in the waiting room 
were obtained in patients referred for ABPM and the relationship 
between the AOBP and awake ABP (mmHg) was examined. In 422 
patients, the mean (±SD) awake ABP (139.4 ± 13.4/80.7 ± 10.6) 
was similar to the mean AOBP recorded in the waiting room 
(140.5 ± 19.8/83.1 ± 11.2), with both values being significantly lower 
than a single office BP (155.1 ± 18.7/90.2 ± 12.7) taken by a nurse. 
They concluded that AOBP readings recorded in a waiting room are 
comparable with the awake ABP, making it possible to obtain AOBP 
in clinical practice without the need to occupy an examining room.
3.2  |  Prior rest period and timing of BP readings
3.2.1  |  Prior rest period
This has been recommended as part of the standardized technique 
for all BP measurements.3,4,7,16,19 However, the quality of this rest 
period has been redefined lately and is now taken as rest in an iso-
lated room with no talking or interaction with anyone.26
3.2.2  |  Timing of BP measurements
These can be pre-clinic, in-clinic, or post-clinic.
BP has often been take pre-clinic, usually by a nurse or trained 
assistant, and this is usually found to be less than the in-clinic BP 
measured by the doctor.12,13
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The post-clinic BP is an interesting concept which has not been 
extensively investigated. In a study from Aga Khan University 
Hospital in Karachi, Pakistan,37 the pre-clinic reading was taken 
by the assessment nurse after the patients waited for 16 ± 1.7 min 
before being seen. The in-clinic reading was taken by the physician 
inside the clinic room after 15 ± 2.1 min wait. After the clinic encoun-
ter was over, participants were asked to be seated, with a prohibition 
of smoking or exertion but not of talking or interaction with others, 
for another 15 min in the waiting area. An interval of 15 min was 
chosen to match the time interval that the patients waited before 
pre-clinic and in-clinic readings were taken. After 15 ± 1.3 min, par-
ticipants were called back to another clinic room where post-clinic 
readings were taken. The two post-clinic readings were taken by a 
research officer at an interval of 1 min. A standard BP measurement 
protocol was observed for all four BP readings. BP was measured 
in the right arm at heart level, while participants were seated in a 
chair with a back-rest. They were asked not to talk during the time 
the readings were taken. All BP readings were taken using an au-
tomated and validated Omron HEM7221-E to avoid inter-observer 
variability. Mean SBP taken pre-clinic, in-clinic, post-clinic 1, and 
post-clinic 2 were 126 ± 20 mmHg, 131 ± 23 mmHg, 126 ± 20 mmHg 
and 121 ± 21 mmHg, respectively (p < .001). Mean DBP taken pre-
clinic, in-clinic, post-clinic 1, and post-clinic 2 were 77 ± 12 mmHg, 
81 ± 13 mmHg, 79 ± 12 mmHg, and 79 ± 11 mmHg, respectively 
(p < .001). The post-clinic 2 SBP and DBP were 10 mmHg and 
2 mmHg lower than the in-clinic SBP and DBP, respectively.37
The same group then repeated the study, this time compar-
ing with ABP also.38 After the post-clinic BP reading was taken, a 
24 h ABPM monitor (SpaceLabs, model: 90217A) was attached to 
each participant which took BP and pulse readings every half hour 
during the daytime and every hour during nighttime. Among the 
three readings taken during a clinic visit, mean (±SD) SBP pre-clinic, 
in-clinic, and 15 min post-clinic were 153.2 ± 23, 152.3 ± 21, and 
140.0 ± 18 mmHg, respectively. Mean (±SD) DBP taken pre-clinic, 
in-clinic, and 15 min post-clinic were 83.5 ± 12, 90.9 ± 12, and 
86.4 ± 11 mmHg, respectively. Mean (±SD) daytime ambulatory 
SBP, DBP, and pulse readings were 134.7 ± 15, 78.7 ± 15 mmHg, 
and 72.6 ± 12/min, respectively. This study replicated the findings 
of their previous study and the post-clinic SBP correlated better 
with the daytime systolic ABP reading than the pre-clinic or in-clinic 
readings. The authors stated that their results were comparable to 
Mancia et al’s study39 which showed that patients’ BP and heart 
rate increased when visited by a physician or a nurse, the rise being 
higher with the physician. Both heart rate and BP then declined, 
over the next 10 min, by about 10/5 mmHg owing to the reduction 
in the alert reaction. Another study showed that serial automated 
office SBP readings taken in a quiet room using the ABPM device 
decreased by about 12 mmHg to reach a plateau over 15 min and 
these readings remained similar at 30 min.40 They concluded that 
post-clinic BP can be more reliable than the conventional methods as 
well as being more cost-effective upfront in comparison with ABPM 
for assessment of hypertension and adjusting medications but fur-
ther studies with a larger sample size are required to determine the 
prognostic value of post-clinic BP and its association with cardiovas-
cular outcomes.38
4  |  PROBLEMS WITH AOBP
It can be seen from the above that AOBP has the best correlation 
with daytime ABP readings. However, as with all other devices, it too 
has its share of problems.
4.1  |  Cost and durability
The upfront cost is 500–900 US dollars (as found on Internet search), 
and there would be additional costs for training and regular mainte-
nance. This is a fairly large figure compared with validated simpler 
oscillometric devices which are about 1/10th the price (this estima-
tion will vary in different countries depending on taxation, pricing 
methodology, availability etc). To make provision for this device for 
even 50% of the practicing doctors in a country would involve a con-
siderable outlay. Then, there is also the question of durability which 
is not clearly defined but these devices will have to be replaced at 
variable intervals.
4.2  |  Validation
This is an essential requirement mentioned in the above guide-
lines and needs to be done according to the Universal Validation 
Standards (WHO Technical Specifications for Automated non-inva-
sive BP measuring devices with cuff, table 3).23 This involves extra 
effort on the part of the manufacturers and regulators, and the users 
have to be aware of the validated lists of models.
4.3  |  Separate room
This may not be a problem for the resource rich countries but is a 
major obstacle in resource poor countries, both in a busy hospital 
outpatient department and in family practices. However, at least one 
study has shown that AOBP readings in a patient resting quietly in a 
waiting room (and not alone in a separate room) were comparable to 
the awake ABP measurements.36
4.4  |  Accuracy and maintenance
The frequency of accuracy checks must be in accordance with man-
ufacturer’s recommendations, which depends on the type of tech-
nology. The usual interval is once every 1 or 2 years. Nevertheless, 
experience indicates that, if an oscillometric device is used fre-
quently every day in clinical practice, the integrity of the cuff and 
tubing and the adequacy of the power source should be checked at 




















































































































































































































































































































































































































































































































































































































































































































































































































































































    |  7SIDDIQUE Et al.
least once a month by users or clinical engineers (WHO Technical 
Specifications for Automated non-invasive BP measuring devices 
with cuff, p. 14).23
4.5  |  Arrhythmias
Standard AOBP device still has problems with accurate meas-
urement of BP in patients with arrhythmias, for example, atrial 
fibrillation.41 In the case of arrhythmia, additional readings by 
auscultation may be required to estimate the average systolic and 
diastolic pressure.16
4.6  |  Masked hypertension
As masked hypertension patients by definition have normal OBP 
measurements, lowering of the office BP by AOBP may increase 
the prevalence of such patients. In a sub-study of the CAMBO 
trial,42 ABP, AOBP, and conventional manual office BP were 
checked. The prevalence for masked hypertension based upon 
both SBP and DBP was similar being 11%–15% for AOBP and 
19%–20% for manual BP patients on single visits, but decreased to 
6% and 10% when readings from the first two visits were used and 
to 4% and 6% when all three visits were used for the AOBP and 
manual BP groups, respectively. The authors concluded that the 
prevalence of masked hypertension is lower with AOBP compared 
with manual BP and the number of patients with masked hyper-
tension decreases if the criteria for having this condition need to 
be met on multiple visits.
4.7  |  Clinical implications on patient-doctor 
relationship
The use of AOBP may have some impact on developing this rela-
tionship. However, this rapport is built by the doctor being present 
and measuring the BP himself/herself, often while carrying on a con-
versation with the patient. It has been seen that these are the very 
actions which are the main reasons of white coat phenomenon and 
falsely high OBP.39
5  |  WHAT DO THE GUIDELINES SAY
Table 1 compares select international guidelines regarding OBP. 
The recommendations are mostly similar with some being more 
detailed than others. The differences are minor and mostly insig-
nificant. The rest period in the Japanese guidelines is mentioned 
as a ‘few minutes’ which is rather non-specific while the others 
all define it as >5 min. The deflation rate is mentioned as 2 mm/s 
in the American and Chinese guidelines and 2 mm/beat in the 
Canadian guidelines while the Japanese guidelines recommends 
2–3 mm/beat or second. The recommended number of readings 
per visit varies from 2–3, with the Canadian guidelines the only 
one eliminating the first reading, and averaging is recommended 
by all. The major difference is perhaps in the recommendations 
for standing BP, both for whom it is necessary and the timing of 
its measurement.
The recommendations for devices in these guidelines are as 
follows;
5.1  |  ESC/ESH 2018 guidelines
“Auscultatory or oscillometric semiautomatic or automatic sphyg-
momanometers are the preferred method for measuring BP in the 
doctor’s office. These devices should be validated according to 
standardized conditions and protocols.”
Presently, the relationship between BP readings ob-
tained with conventional office BP measurement and 
unattended office BP measurement remains unclear, 
but available evidence suggests that conventional of-
fice SBP readings may be at least 5–15 mmHg higher 
than SBP levels obtained by unattended office BP 
measurements. There is also very limited evidence on 
the prognostic value of unattended office BP mea-
surements, i.e. whether they guarantee at least the 
same ability to predict outcomes as conventional of-
fice BP measurements.3
Thus, the ESC/ESH guidelines recommend both auscultatory and 
oscillometric devices with the proviso that all devices should be vali-
dated and but with no preference for one over the other. AOBP is men-
tioned but with lack of clarity about its prognostic value.
5.2  |  ACC/AHA 2017 Guidelines
The clinical standard of auscultatory measures cali-
brated to a column of mercury has given way to oscil-
lometric devices.
…only devices with validated measurement protocol 
can be recommended for use.
Although much of the available BP-related risk in-
formation and antihypertensive treatment trial ex-
perience have been generated by using “traditional” 
office methods of BP measurement, there is a grow-
ing evidence base supporting the use of automated 
office BP measurements.4
The ACC/AHA guidelines thus prefer validated oscillometric de-
vices with a bias toward AOBP.
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5.3  |  Hypertension Canada’s 2020 guidelines
Use of standardized measurement techniques and in-
dependently validated equipment for all methods (au-
tomated OBPM (AOBP), OBPM, ABPM, and HBPM) 
is recommended. Unless specified otherwise, mea-
surement using electronic (oscillometric) upper arm 
devices is preferred over auscultation.
AOBP is the preferred method of performing OBPM.16
Thus, the Canadian Hypertension guidelines generally allow only 
oscillometric devices with AOBP being the preferred method for 
OBPM for both screening and management. It further specifies that 
diagnosis should be based on ABPM or HBPM and not on OBPM.
5.4  |  Japanese hypertension guidelines 2019
Office blood pressure is measured by the ausculta-
tion method, which is the standard procedure, but the 
use of an automatic sphygmomanometer of the upper 
arm type is also permitted.7
The first choice for OBP, therefore, remains the auscultatory 
method although it is mentioned that mercury sphygmomanometers 
will be banned from January 1, 2021.
5.5  |  Chinese hypertension guidelines 2018
Upper arm medical electronic sphygmomanometer, 
which has been validated by international standard-
ized protocols (ESH, BHS and AAMI), or mercury 
sphygmomanometer, which is up to the metrological 
standard (will be deprecated gradually), are used for 
the measurement. Automated office BP measure-
ment (AOBP) can reduce the white coat effect, which 
is worthy of further research and promotion.19
The emphasis here is on the oscillometric device while the mercury 
sphygmomanometer is still allowed and the AOBP is mentioned but 
more for research.
6  |  SPECIFIC A SIAN ISSUES
Asia is a very diverse continent in terms of resources, both economi-
cally and for human resource. Even within a single country, there are 
areas, mostly urban, which are rich but have expensive human re-
source while there are other areas, usually rural, which are poor with 
abundant human resource and inadequate technical back up. AOBP 
may be the ideal choice for the former while the simple oscillometric 
device may be better for the latter. Although most countries have 
signed the Minamata declaration, some of the under developed ones 
have not got it ratified from their respective parliaments and are 
not implementing it. These countries continue to use the mercury 
sphygmomanometer despite its multiple problems as stated above. 
In general, clinics and hospitals with adequate financial resources 
and access to technical back up would be better served by AOBP 
while those lacking these can choose the simple oscillometric device.
7  |  CONCLUSION
Conventional OBP methods of auscultatory mercury or aneroid 
devices are both not recommended by WHO, the former due to 
mercury toxicity and the latter due to frequent need for recalibra-
tion. Also, both these methods need well trained personnel and are 
prone to white coat phenomena as these cannot be unattended. 
Oscillometric devices are recommended with the unattended, fully 
automated, AOBP giving the best results. However, due to the en-
hanced cost and area requirements it cannot be recommended as the 
primary method in resource poor countries at present. Moreover, 
general usage of this device would impact the BP levels for both di-
agnosis and treatment as there is a 5–15 mmHg reduction in SBP lev-
els with AOBP compared with conventional methods as mentioned 
in the ESC guidelines above. This point would need another review.
The alternative would be the self-initiated oscillometric device, 
duplicating the rest and isolation protocol used in SPRINT if possi-
ble. This too may be difficult due to area constraints in busy outpa-
tient departments of hospitals and family practices. In which case, 
the post-clinic method may be useful in obtaining a reading closer to 
daytime ABP reading. However, this method needs more validation 
with further studies in different population groups. Finally, it may 
be mentioned that with the rapid development in cuff-less technol-
ogies, all this may be obsolete in the not too distant future and we 
may all be measuring our BP on mobile phones.
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